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#{149} biotin-streptavidin interaction
The polymerase chain reaction (PCR) has proved useful for the follow-up of HIV-l infection [1] [2] [3] [4] [5] [6] [7] and especially for neonatal diagnosis of children born to HIlT-1-infected mothers [8] [9] [10] [11] . [11, 12] i This method has high specificity and sensitivity [11, 13] 
HW-

ASSAY COMPONENTS
Primer selection. The two pairs of primer used, SK38i/SK39i and GAGO4/GAGO6 (Table 1) , were both located in the HIV-l GAG gene. The SK38iJSK39i primer pair is derived from the previously described SK38/SK39 primer pair [Ii, 17] . The HIV-1 polymorphic nucleotide positions in the primers were found by performing a sequence alignment of 15 strains of I-lilT-1 by using the Clustal software (Fig. 1 ). They were obtained from GenBank (genetic sequence databank, National Center for Biotechnology Information, Bethesda, MD) and consisted of HJVBRUCG, I-IIVELICG, HIVH3CG, H1VJRCSF, H1VMALCG, REHTLV3, AIARV2, HTVH3BH5, HIVOY, H1VRF, REI-IIVHXB, REHIVJH3, REHIVMNC, REH1VNL4, REHTVZ2Z. We incorporated 3 inosines into primer SK38i and 4 inosines into primer SK39i, corresponding to, respectively, positions 3, 18, and 24 and positions 3, 6, 9, and 23 from the 5' end of the primer.
The GAGO4 and GAGO6 inosine-substituted primers were as described by Piatak et al. [7, 14] . Primers SK38i and GAGO4 were biotinylated at the 5' end during oligonucleotide synthesis.
SK381/SK39i
internal control preparation. The internal control was obtained by PCR by using a mutational primer that deleted 14 bp in the sequence of the native HIV-l GAG gene ( Fig. 2A ).
The SK39i primer is located at the 3' end of the amplified region. The mutational primer is located at the 5' end of the amplified region, at position + 1132 to + 1148 of the GAG gene.
At the 5' extremity, the mutational primer has a tail composed of the SK38i primer sequence that is complementary to the region + 1090 to + 1116 of the GAG gene (Table 1) . Thus, amplification of such a PCR product with SK38i/SK39i yields a PCR product 14 bp shorter than a native HIV-l PCR product.
The PCR was performed by using a previous SK38i/SK39i Probe selection. The SK1O2 probe previously described [12] hybridizes to the GAGO4/GAGO6 biotinylated PCR products. The viral probe (VP38i/39i) and the internal control probe (IC38i/39i) were chosen so as to specifically detect either the viral or the internal control SK38i/SK39i PCR product (see specifically hybridize to the PCR products from the viral DNA and the internal control, respectively (Table 1) . Cross-hybridization was controlled for, and the two probes were found to be highly specific. We did not incorporate inosine into these probes because the hybridization and washing conditions used here were at low stringency and did not differentiate point mutations. 
SK3Bi SK39i
Viral probe
Viral genome SK39i
*CC* * *CAGCATT*TGGACATAAGACA*GG*CC *AA*GAACC*TTTAGAGA +1218 Internal control probe PCR, 20 copies of the internal control (in 10 .tL) were also added. A blank PCR was run under the same conditions.
Biotin was also incorporated during PCR via dATP-biotin 11 (Gibco BRL) by the Taq polymerase.
PCR conditions were the same except that the biotinylated primers SK38i and GAGO4 were replaced by unmodified primers, and dATP-biotin 11(12.5 j.tmoVL) was added to the PCR mix.
The samples were incubated at 50 #{176}C for 10 mm to allow T.JDG to digest any PCR contamination.
The PCR consisted of a 5-mm denaturation at 95 #{176}C, followed by 40 cycles, each for 1 mm at 95 #{176}C, 1 mm at 55 #{176}C, and 1 mm at 72 #{176}C. The PCR products were kept at 72 #{176}C, then moved into a separate room for analysis. Without delay, 5 L of 1 mol/L NaOH was then added to inactivate UDG and to denature the amplified products.
MICROTITER PLATE HYBRIDIZATION ASSAY
The \TP38i/39i, SK1O2 [12] , and IC38i/39i oligonucleotide probes were covalently bound to clear microtiter plates [18] .
[ 
DATA ANALYSIS
Before beginning interpretation, the signal of the negative detection control (or background) had to be low, <50 arbitrary fluorescence units with our Microfluor fluorometer. Moreover, the negative detection control and the negative PCR control had to have similar values if we were to eliminate false-positive results produced by PCR contamination. Furthermore, the signal obtained with the internal control probe (1C38i139i) had to be at least 5 times that of the negative detection control to eliminatethe possibility thata PCR inhibitor was presentin the tested sample.
Because the value of the negative detection control could vary with the conservation state of the substrate (possibility of spontaneous dephosphorylation), we interpreted each experiment according to its background value. A sample was considered negative when the signals from both viral probes VP38i/39i and SK1O2 were less than twice that of the negative detection control. The negative cutoff value was determined by studying a population of 100 HIV-l-negative controls. Results from each experiment were expressed as the ratio of fluorescence emission, sample/background.
For example, in a series of 25 HIV-lnegative controls, the mean (± SD) ratio for sample/background was 1.16 ± 0.19 and thus less than two times the background.
In HIlT-i-negative controls, the mean value ± 3 SD was always less than twice the negative control background.
A sample was considered positive if one of the two viral probes had a signal 5 times that of the PCR negative control.
The positive cutoff value we used was determined by studying 40 HilT-i-infected patients. The lowest values were always >5 times the background.
When the fluorescence emission of a sample ranged between 2 and 5 times the background, we performed a second PCR to confirm or rule out infection with HIV-1.
OLIGONUCLEOTIDE SOLUTION HYBRIDIZATION
OSH was performed as previously described [11, 12] .PCR products were precipitated with ethanol. After centrifugation, the pellets were dissolved in 10 L of "FABH" buffer: 800 mL/L deionized fonmamide, 0.4 molJL NaCI, 40 mmol/L 1,4-piperazmnediethanesulfonic acid (pH 6.4), and 1 mmol/L EDTA (pH 8.0). The SK19 oligonucleotide was 5'-end labeled with [y-32P]ATP by use of a polynucleotide kinase. We added 5 ng of 32P-end-labeled SK19 probe to the reaction mixture, 
Results
TECHNICAL CHARACTERISTICS
Taq polymerase inhibitors such as hemoglobin, high DNA concentration, or cellular membranes can lead to false-negative results. These inhibitors were detected by the internal control that was added to the PCR SK38i/SK39i reaction. Two copies of the internal control could be detected with this technique. However, when the internal control was amplified with the i0 PBMC cell lysate, 20 copies were necessary to obtain reproducible results. This quantity was kept low to favor viral amplification and to be sensitive to any PCR inhibitor.
Because the internal control always had to be positive, we could thus distinguish negative samples from nonamplified samples. Using a biotinylated primer instead of dATP-biotin incorporation during PCR increased the sensitivity of the assay ( Table 2 shows the positive control/ negative control ratio of results obtained with the two substrates at different enzymatic reaction times. The 4-MUP fluorescent substrate seemed to be more convenient than the colonimetric substrate and gave a fivefold higher controls ratio for a 15-mm reaction time (11.5 vs 2.5). Chemiluminescent substrates, such as dioxetane substrates, were not tested because they need a specific detection system less widely used in clinical laboratories.
FLUOROMETRIC DETECTION AND RADIOISOTOPIC
OSH COMPARISON
The sensitivity of the fluorometnic detection system was first compared with that of radioisotopic OSH by retrospectively studying 38 OSH-positive samples. Using the SK38i/SK39i primers, we performed a PCR amplification of cell lysates from these samples and detected the fluorescence of the biotinylated PCR products after hybridization to the SK38i/39i probe. All 38 samples were positive by the fluorometnic detection system. Moreover, a prospective study of 70 samples by both methods gave 100% correlation between the OSH method and the fluorometric test. Among the 70 samples, 18 were positives, and the signal intensities were comparable for both methods (Fig. 3) .
CLINICAL
TRIAL:
A PROSPECTIVE STUDY
We have been routinely using fluorometric detection for 6 months and have tested 115 samples. Table 3 shows some typical results obtained with our technique, and all the results obtained with the SK38i/SK39i primers, expressed as sample/background ratio, are plotted in Fig. 4 (results obtained with the GAGO4/ GAGO6 primers were very similar). The samples were from 10 known infected mothers and 54 newborns born to HIlT-iinfected mothers, and some patients were followed for several The samples were amplified with the SK38i/SK39i and the GAGO4/GAGO6 primer pairs and were also tested by viral culture and (or) HIV-1 serology [4] .
Among the 115 samples tested, 18 were positive; of these, 16 were positive with both primer pairs, and 2 were positive with the GAGO4/GAGO6 primers but negative with the SK38iJ39i primers. The PCR results agreed well with the results of viral culture, HIlT-I antibody detection, or p24 antigenic detection (P <0.01, Kappa test). In only two cases were discrepancies found. PCR was positive for one newborn for whom the simultaneous viral culture and p24 antigen detection were negative; however, HIlT-1 infection of this patient was confirmed by a positive viral culture at age 3 months. The one false-negative sample was from a seropositive mother for whom the amplification with the two pairs of primers was negative despite a positive signal for the internal control. Follow-up of the 54 children for 6 months did not reveal any false-negative or false-positive initial PCR results. The sensitivity of this fluorometric microtiter detection assay was 99% (one false-negative result among 115 tested samples) and specificity was 100% for this prospective study.
Discussion
Several PCR-based methods for detecting HIV-1 DNA without the use of radioisotopes have been developed by Roche Diagnostic Systems, Du Pont, and Gen-Probe, but these commercial kits lack the controls and safeguards that we have incorporated into this test. The UDG system, an effective safeguard against contamination by previous PCR products /7] , is only proposed in the Roche detection system. Because of the high variability of the I-IIV-l viral genome, the amplification of two different regions theoretically improves the sensitivity of the detection. However, only the Gen-Probe kit supplies two independent primer pairs. Finally, none of these kits uses primers containing inosine at polymorphic nucleotide positions or includes an internal control to detect false negatives that result when a Taq polymerase inhibitor is present. We combined several technical improvements to optimize the sensitivity and the specificity of the test. The specificity is ensured by hybridization of the amplified samples to HIlT-Ispecific probes (SK1 02 and VP3 8i/39i In fact, however, we observed in two cases a positive PCR result with the GAGO4/ GAGO6 primers when the SK38i/SK39i result was negative.
Because we did not sequence the HW-l GAG gene, we were not primers.
115 samples were tested and the results were expressed as a ratio (R = sample/background) of the fluorescence emission intensity. In all, 99 patients were found to be negative (R <2), and 16 were positive (R >5).
able to demonstrate whether these results were caused by new mutations.
False-negative results caused by the presence of PCR inhibitors in the cell lysate were detected by the use of an internal control.
The internal control and the proviral DNA were coamplified with the same pair of primers. These targets have an equivalent PCR efficiency because the two PCR products have a similar sequence except for a 14-bp deletion in the internal control. Twenty copies of the internal control were added before PCR: Because the HW-l burden is low, amplification of the 20 copies will be sensitive to any PCR inhibitors. Some authors have coamplified cellular internal controls (single copy of a human gene or endogenous RNA) with the HIlT-1 genome to control for the presence of PCR inhibitors.
Those controls also test for the DNA or RNA extraction. Instead, we chose a synthetic control because the viral burden could be very low in comparison with the genome copy number. Moreover, because we used the same primer pairs, the influence of PCR inhibitors would affect amplification of the HW-l genome in the same way as that of the internal control. 
